Evaluation of 6-aminonicotinamide (NSC-21206) in the treatment of metastatic hypernephroma.
D000230:Adenocarcinoma / Q000188:drug therapy*; D000328:Adult; D000368:Aged; D002986:Clinical Trials as Topic; D005069:Evaluation Studies as Topic; D005260:Female; D005500:Follow-Up Studies; D005928:Glossitis / Q000139:chemically induced; D006801:Humans; D007680:Kidney Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D009365:Neoplasm Regression, Spontaneous / Q000139:chemically induced; D009536:Niacinamide / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D010612:Pharyngitis / Q000139:chemically induced; D013280:Stomatitis / Q000139:chemically induced; D014012:Tinnitus / Q000139:chemically induced
D009536:Niacinamide